Federal judge halts Trump's executive orders targeting diversity, equity, and inclusion programs, citing concerns over free speech and arbitrary enforcement.
FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients.
Federal judge halts Trump's executive orders targeting diversity, equity, and inclusion programs, citing concerns over free speech and arbitrary enforcement.
FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients.